跳至主要内容
临床试验/IRCT2014083018973N1
IRCT2014083018973N1已完成2 期

Effect of Levetiracetam mono therapy in comparison with Sodium Valproate on juvenile myoclonic epilepsy

Deputy for research affairs of Shahrekord University of Medical Scince0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
8 years 至 25 years(—)
性别
All

入选标准

  • Inclusion criteria included patients how have JME (Juvenile Myoclonic epilepsy ) with two myoclonus and no EEG changes; or a Myoclonus with EEG changes, which this changes include specific changes (3-6Hz spike / polyspike slow wave discharge); epilepsy should start at 8 to 25 years old.
  • The exclusion criteria included, neurological disorders; mental disorder; history of pseudoseizures; history of mental or mood disorder; the use of drugs affecting the central nervous system in a month before beginning of the study; metabolic disorders; infectious disease; malignancy; pregnancy and disease that their treatment interact with valproate sodium or Leveteracetam.

排除标准

  • 未提供

研究者

发起方
Deputy for research affairs of Shahrekord University of Medical Scince

相似试验